- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
케어 전환에 대한 임상 시험
총 143870 건
-
Sandy SrinivasGlaxoSmithKline완전한방광암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전) | 방광(Urothelial, Transitional Cell) 암 표재성(비침습성) | 방광(Urothelial, Transitional Cell) 암 전이성 또는 절제 불가능미국
-
Stanford UniversityNational Institutes of Health (NIH)빼는방광암 | 피부암 | 방광(요로상피, 이행세포) 암 | 방광(Urothelial, Transitional Cell) 절제 가능한 암(방광절제술 전)미국
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH)완전한
-
Mark WilliamsUniversity of Pennsylvania; University of Illinois at Chicago; Boston Medical Center; Kaiser... 그리고 다른 협력자들완전한
-
University of PennsylvaniaRita & Alex Hillman Foundation초대로 등록
-
University of PennsylvaniaUnitedHealth Group완전한
-
University of ChicagoWashington University School of Medicine; Agency for Healthcare Research and Quality (AHRQ) 그리고 다른 협력자들아직 모집하지 않음
-
University of WashingtonAgency for Healthcare Research and Quality (AHRQ)모병
-
Assistance Publique - Hôpitaux de Paris완전한
-
Lisa TuchmanHealth Resources and Services Administration (HRSA)완전한케어 코디네이션 | 건강 관리 전환
-
University of RochesterAcademic Pediatric Association완전한
-
University of PennsylvaniaAgency for Healthcare Research and Quality (AHRQ)아직 모집하지 않음
-
Brigham and Women's HospitalCrico완전한부작용 | 치료의 전환 | 일반 의학 | 퇴원 체크리스트미국
-
Vanderbilt University Medical CenterNational Institute on Aging (NIA)완전한
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna모병
-
University of PittsburghWashington University School of Medicine; National Institute on Aging (NIA)모집하지 않고 적극적으로
-
Mayo Clinic완전한
-
Brigham and Women's HospitalAgency for Healthcare Research and Quality (AHRQ); Crico완전한부작용 | 재입학 | 환자 포털 | 치료의 전환 | 일반 의학 | 퇴원 체크리스트 | 환자-제공자 커뮤니케이션미국
-
Ohio State UniversityAmerican Society of Health-System Pharmacy Foundation빼는
-
University of Pennsylvania완전한이 프로토콜에 참여하는 피험자는 초기 CART-EGFRvIII 주입 후 최대 15년 동안 추적 관찰됩니다.미국
-
Associació per a la Recerca Oncologica, Spain알려지지 않은
-
Cliniques universitaires Saint-Luc- Université...Novartis종료됨
-
The Lymphoma Academic Research OrganisationNovartis; Gilead Sciences모병
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbH모병
-
Henry T. Stelfox, MD PhDCanadian Institutes of Health Research (CIHR); Alberta Health services; Canadian Frailty...완전한
-
Johns Hopkins UniversityAgency for Healthcare Research and Quality (AHRQ)완전한
-
Shaheen AlaneeMerck Sharp & Dohme LLC알려지지 않은
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)모집하지 않고 적극적으로이행 세포 암종 | 전이성 요로상피암 | 절제 불가능한 이행 세포 암종미국
-
UroGen Pharma Ltd.완전한
-
Memorial Sloan Kettering Cancer CenterNovartis완전한
-
Shanghai General Hospital, Shanghai Jiao Tong University...모병
-
University of RochesterNational Institute on Aging (NIA)완전한
-
Institute of Cancer Research, United KingdomCancer Research UK알려지지 않은
-
Trillium Health PartnersCentre for Aging and Brain Health Innovation알려지지 않은
-
Ohio State University Comprehensive Cancer Center완전한
-
Thekla BrunkertHealth Department of the Canton of Basel-Stadt모병
-
Shanghai International Medical Center알려지지 않은
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.아직 모집하지 않음Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited중국
-
Ningbo Cancer Hospital알려지지 않은
-
UroGen Pharma Ltd.빼는
-
Holbaek SygehusRegion Sjælland; Danish Institute for Public Health완전한